IndraLab

Statements

6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one inhibits MAPK8. 1 / 4

3 | 1

reach

"Furthermore, the activation of Syk and JNK upon P. multocida infection was assessed by detecting phosphorylated Syk or JNK, and the p-Syk or p-JNK was inhibited by the inhibitor R406 and SP, respectiv[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

30955811

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one inhibits MAPK8. 1 / 4

INDRA sources:

Databases

Reading